Site #333 — Eugene, Oregon

Site #333 is a clinical research site located in Eugene, Oregon, United States 97401.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site #333 has participated in 1 clinical trials.

Therapeutic areas: Presbyopia, Near Vision, Refractive Error.

Sponsors: LENZ Therapeutics, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Eugene

Browse all research sites in Oregon · View every site in Eugene

• University of Oregon
• University of Oregon, Lewis Integrative Sciences Building
• Remote study offered by the University of Oregon
• Prevention Science Institute, University of Oregon
• Institute for Health in the Built Environment, University of Oregon
• Oregon Health & Sciences University
• Bowerman Sports Science Center at the University of Oregon
• University of Oregon Prevention Science Institute
• University of Oregon - Social Affective Neuroscience Lab
• University of Oregon, Social and Affective Neuroscience Laboratory
• Ohio State University Telemedicine
• Northwest Christian University

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #333?

Site #333 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #333 conducted?

Site #333 has 1 clinical trials on record. Their work covers Presbyopia, Near Vision, Refractive Error.

Is Site #333 accredited by Crixeo Clinical Trials?

Site #333 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #333?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.